These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12468355)

  • 1. Major hepatectomy at interval debulking for stage IV ovarian carcinoma: a case report.
    Chi DS; Temkin SM; Abu-Rustum NR; Sabbatini P; Jarnagin WR; Blumgart LH
    Gynecol Oncol; 2002 Oct; 87(1):138-42. PubMed ID: 12468355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer.
    Gasparri ML; Grandi G; Bolla D; Gloor B; Imboden S; Panici PB; Mueller MD; Papadia A
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1509-20. PubMed ID: 26660323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit.
    Bacalbasa N; Dima S; Brasoveanu V; David L; Balescu I; Purnichescu-Purtan R; Popescu I
    World J Surg Oncol; 2015 Aug; 13():235. PubMed ID: 26243426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer.
    Lim MC; Kang S; Lee KS; Han SS; Park SJ; Seo SS; Park SY
    Gynecol Oncol; 2009 Jan; 112(1):28-34. PubMed ID: 19010521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery for isolated liver metastasis of ovarian cancer.
    Pekmezci S; Saribeyoglu K; Aytac E; Arvas M; Demirkiran F; Ozguroglu M
    Asian J Surg; 2010 Apr; 33(2):83-8. PubMed ID: 21029944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic resection for metachronous metastases from ovarian carcinoma.
    Merideth MA; Cliby WA; Keeney GL; Lesnick TG; Nagorney DM; Podratz KC
    Gynecol Oncol; 2003 Apr; 89(1):16-21. PubMed ID: 12694649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver.
    Roh HJ; Kim DY; Joo WD; Yoo HJ; Kim JH; Kim YM; Kim YT; Nam JH
    Arch Gynecol Obstet; 2011 Nov; 284(5):1223-9. PubMed ID: 21132314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major hepatectomy and right hemicolectomy at the time of primary cytoreductive surgery for advanced ovarian cancer: report of a case.
    Chalkiadakis GE; Lasithiotakis KG; Petrakis I; Kourousis C; Georgoulias V
    Int J Gynecol Cancer; 2005; 15(6):1115-9. PubMed ID: 16343191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases.
    Naik R; Nordin A; Cross PA; Hemming D; de Barros Lopes A; Monaghan JM
    Gynecol Oncol; 2000 Aug; 78(2):171-5. PubMed ID: 10926798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors.
    Mateo R; Singh G; Jabbour N; Palmer S; Genyk Y; Roman L
    Gynecol Oncol; 2005 Apr; 97(1):266-70. PubMed ID: 15790474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic resection of giant metastatic tumor from clear cell carcinoma of the ovary.
    Kawagishi N; Shirahata Y; Ishida K; Satoh K; Enomoto Y; Akamatsu Y; Sekiguchi S; Fukumori T; Fujimori K; Satoh A; Moriya T; Satomi S
    J Hepatobiliary Pancreat Surg; 2005; 12(2):155-8. PubMed ID: 15868082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer.
    Kolev V; Pereira EB; Schwartz M; Sarpel U; Roayaie S; Labow D; Momeni M; Chuang L; Dottino P; Rahaman J; Zakashansky K
    Int J Gynecol Cancer; 2014 Jan; 24(1):70-4. PubMed ID: 24356412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic resection for recurrent metastatic ovarian cancer.
    Abood G; Bowen M; Potkul R; Aranha G; Shoup M
    Am J Surg; 2008 Mar; 195(3):370-3; discussion 373. PubMed ID: 18207130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of hepatic resection in the treatment of hepatic parenchymal metastasis of recurrent epithelial ovarian carcinoma].
    Yan X; Bao Q; An N; Gao YN; Jiang GQ; Gao M; Zheng H; Wang W
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):132-7. PubMed ID: 21575484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?
    Perri T; Ben-Baruch G; Kalfon S; Beiner ME; Helpman L; Hogen LB; Shapira-Frommer R; Korach J
    Gynecol Oncol; 2013 Oct; 131(1):27-31. PubMed ID: 23880152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate Recommendations for Surgical Debulking in Stage IV Ovarian Cancer.
    Chern JY; Curtin JP
    Curr Treat Options Oncol; 2016 Jan; 17(1):1. PubMed ID: 26714493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.
    Morimoto A; Nagao S; Kogiku A; Yamamoto K; Miwa M; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Fujiwara K
    Jpn J Clin Oncol; 2016 Jun; 46(6):517-21. PubMed ID: 26977055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Survivors After Liver Resection for Ovarian Cancer Liver Metastases.
    Bacalbaşa N; Balescu I; Dima S; Popescu I
    Anticancer Res; 2015 Dec; 35(12):6919-23. PubMed ID: 26637917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observation on the surgical aspect of resection of noncolorectal nonneuroendocrine hepatic parenchymal metastasis in patients with primary epithelial ovarian carcinoma.
    Farghaly SA
    Gynecol Oncol; 2009 Nov; 115(2):319; author reply 319-20. PubMed ID: 19446315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.